The University of Chicago Header Logo

Connection

Michael Becker to Imatinib Mesylate

Back to Details
This is a "connection" page, showing publications Michael Becker has written about Imatinib Mesylate.
Michael Becker
Connection Strength
0.019
Imatinib Mesylate
  1. Phase I study of cladribine, cytarabine (Ara-C), granulocyte colony stimulating factor (G-CSF) (CLAG Regimen) and simultaneous escalating doses of imatinib mesylate (Gleevec) in relapsed/refractory AML. Leuk Res. 2008 Dec; 32(12):1830-6.
    View in: PubMed
    Score: 0.019
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.